SCHEMBL7233370

SCHEMBL7233370

C=CCOC(=O)c1cc(N)cc(C(=O)N(C)OC)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.40
HSD17B10 Q99714 2/20 0.40
TSHR P16473 1/20 0.40
SNCA P37840 1/20 0.39
CYP3A4 P08684 2/20 0.38
NPC1 O15118 1/20 0.36
POLB P06746 1/20 0.34
PHLPP2 Q6ZVD8 1/20 0.34
KDM4E B2RXH2 2/20 0.34
TP53 P04637 1/20 0.34
HPGD P15428 1/20 0.34
ATAD2 Q6PL18 1/20 0.34
MAPT P10636 3/20 0.33
MLYCD O95822 1/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
LMNA P02545 2/20 0.32
GAA P10253 1/20 0.32
MAPK1 P28482 1/20 0.32
CYP1A2 P05177 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7235417 0.90 ALDH1A1 (0.40) ALDH1A1HSD17B10TSHRSNCACYP3A4
SCHEMBL8909585 0.88 NPC1 (0.41) ALDH1A1HSD17B10TSHRSNCACYP3A4
SCHEMBL5095083 0.84 ALDH1A1 (0.51) ALDH1A1HSD17B10TSHRSNCACYP3A4
SCHEMBL5095256 0.83 ALDH1A1 (0.45) ALDH1A1HSD17B10TSHRSNCACYP3A4
SCHEMBL7242780 0.83 NPC1 (0.44) ALDH1A1SNCANPC1POLBMAPT
SCHEMBL5557935 0.81 ALDH1A1 (0.51) ALDH1A1HSD17B10TSHRSNCACYP3A4
SCHEMBL6975620 0.80 ATAD2 (0.46) ALDH1A1HSD17B10TSHRPOLBKDM4E
SCHEMBL5108935 0.79 ALDH1A1 (0.46) ALDH1A1HSD17B10TSHRSNCACYP3A4
SCHEMBL5101798 0.78 ALDH1A1 (0.43) ALDH1A1HSD17B10TSHRSNCACYP3A4
SCHEMBL5109264 0.77 ALDH1A1 (0.45) ALDH1A1HSD17B10TSHRSNCACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6541491-B1 Treating ras mediated diseases, especially cancer. ZENECA LIMITED (GB) 2003-04-01 US disclosed
US-6232338-B1 4-Mercaptopyrrolidine derivatives as farnesyl transferase inhibitors ZENECA LIMITED (GB) 2001-05-15 US disclosed
EP-0842151-A1 4-MERCAPTOPYRROLIDINE DERIVATIVES AS FARNESYL TRANSFERASE INHIBITORS ZENECA LIMITED (GB) 1998-05-20 EP disclosed
WO-1997006138-A1 4-MERCAPTOPYRROLIDINE DERIVATIVES AS FARNESYL TRANSFERASE INHIBITORS ZENECA LIMITED (GB) 1997-02-20 WO disclosed